NewsFeed Voices Science Insight Innovation
October, 2025
October 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Breaking Insights from Dr. Akhil: 2025 Global Platelet Transfusion Guidelines Unveiled – What’s In, What’s Out
Dr. Akhil/X
Jun 2, 2025, 07:10

Breaking Insights from Dr. Akhil: 2025 Global Platelet Transfusion Guidelines Unveiled – What’s In, What’s Out

A snapshot review of evidence-based thresholds and recommendations for platelet transfusion from Dr. Akhil on X:

Summary Breakdown – “Recommendations for Platelet Transfusion”
This table from the 2025 AABB and ICTMG clinical practice guidelines provides a tiered approach to platelet transfusion, based on population, clinical scenario, and quality of evidence

    “Platelet Transfusion:- 2025 AABB and ICTMG International Clinical Practice Guidelines
Strong Recommendations
These are based on moderate to high certainty of evidence and clearly defined platelet thresholds.Population When to Transfuse Threshold Certainty
  • Nonbleeding patients with hypoproliferative thrombocytopenia (e.g., chemo, SCT) Transfuse <10 × 10³/μL:  Moderate
  • Preterm neonates without bleeding Transfuse <25 × 10³/μL:  High
  • Lumbar puncture Transfuse <20 × 10³/μL:  Moderate
  • Dengue patients without major bleeding: No transfusion — Moderate
Key Message: Liberal transfusion policies (e.g., at 50 × 10³/μL) are no longer supported; stricter thresholds are both safer and evidence-based.Section 2: Conditional RecommendationsThese have low or very low certainty and apply to more nuanced clinical situations.Clinical Setting Transfusion Strategy Certainty
  • Adult nonbleeding patients (autologous SCT/aplastic anemia): No prophylaxis Low to very low
  • Critical illness (non-Dengue) without bleeding Transfuse if <10 × 10³/μL: Very low
  • Central venous catheter placement Transfuse if <10 × 10³/μL: Moderate to very low
  • Interventional radiology Transfuse if <20 × 10³/μL (low risk) or <50 × 10³/μL (high risk): Very low
  • Major non-neuraxial surgery Transfuse if <50 × 10³/μL: Very low
  • Nonthrombocytopenic cardiovascular surgery (no bleeding): No transfusion – Very low
  • Intracranial hemorrhage (>100 × 10³/μL) on antiplatelets: No transfusion-  Low to very low
Clinical Takeaways:
  • Restrictive transfusion thresholds (<10–20 × 10³/μL) are widely favored, even for invasive procedures.
  • Platelet transfusion is not recommended in several settings where bleeding is not present, including:
  • Dengue-associated thrombocytopenia
  • Intracranial hemorrhage with normal/high platelet counts
  • Cardiovascular surgery without thrombocytopenia
  • High-risk interventions may require transfusion at slightly higher thresholds (e.g., <50 × 10³/μL), but this is based on low certainty evidence.”

2025 AABB and ICTMG International Clinical Practice Guidelines

You can find the details in Hemostasis Today.

Bleeding Disorders Guidelines Coagulation updates Evidence-based hematology Hematology Hematology publication Hemostasis Hemostasis research Hemostasis Today Platelet transfusion Platelet Transfusion Guidelines Thrombosis and hemostasis
Insight
Science
Innovation
Voices
Insight
Oct 30, 2025, 12:12
Laura Ceci Galanos Reflects on WSC 2025
Voices
Oct 30, 2025, 11:56
Lucas de Vries Defends His PHD Combining Physics, Deep Learning and Medical Imaging
Science
Oct 30, 2025, 05:14
Umberto Pensato on Reperfusion Outcomes in Stroke
Insight
Oct 30, 2025, 03:53
Michael Makris on Biomarin's Decision to Divest Roctavian
Voices
Oct 30, 2025, 03:50
Laura Bouvet Receives the Young Investigator Award at ECTH 2025
Insight
Oct 29, 2025, 10:39
UMR1011 Researchers at ECTH 2025
Voices
Oct 29, 2025, 08:30
ECTH 2025․ Advancing the Science of Thrombosis and Haemostasis Together
Science
Oct 29, 2025, 07:18
Osimertinib Has Transformed Lung Cancer Care — But at What Cost to the Heart?
Science
Oct 29, 2025, 07:15
From the Lab to Prague․ Our ECTH 2025 Experience
Science
Oct 29, 2025, 07:13
Amol Akhade: Happy To Share Our Paper Published In Lancet Oncology
Insight
Oct 29, 2025, 07:09
Hritvik Jain and Andrew Goldsweig Sharedrisk About the Risk of MACCE, AMI, and readmission in IBD patients undergoing PCI
Science
Oct 29, 2025, 07:09
Davide Capodanno: This Time It’s About the Timing of Complete Revascularization in ACS